Figure 3. Immunological analyses of Th17 and Treg. Time 1 refers to before nivolumab administration. Time 2 and Time 3 refer to 2 and 4 weeks after nivolumab administration, respectively. Closed triangle, open square, and open circle showed long stable disease (SD) cases, conventional hyper-progressive disease (HPD) cases, and super HPD case, respectively.
